Lynch Carpenter, LLP is investigating claims against HealthEquity related to this data breach. If you've received a data breach notification from HealthEquity, you may be entitled to compensation. 1https://www.maine.gov/agviewer/content/ag/985235c7-cb95-4be2-8792-a1252b4f8318/2ec3e314-5731-49d0- a937-6dc22c6b24f3.html. 2 Id. About Lynch Carpenter If you have received a notification from HealthEquity that your information was impacted, please call Patrick Donathen at (412) 322-9243, email him at patrick@lcll ...

Core Viewpoint - HealthEquity, Inc. has shown strong performance with a 29.3% stock gain over the past year, significantly outperforming the industry and S&P 500 [1] Company Performance - HealthEquity's market capitalization stands at $6.94 billion, with projected growth of 28% over the next five years [10] - The company has consistently surpassed earnings estimates, with an average earnings surprise of 17.2% over the trailing four quarters [10] - In the first quarter of fiscal 2025, HealthEquity reported solid top-line and bottom-line performances, benefiting from robust contributions across all revenue sources [13] Business Model and Strategy - HealthEquity employs a business-to-business-to-consumer distribution strategy, aiming to expand its service offerings to current clients [11] - The company has a diverse distribution footprint targeting enterprise and regional employers, as well as potential network partners [11] Strength in Health Savings Accounts (HSA) - As of April 30, 2024, the total number of HSAs increased by 13.1% year over year, with 665,000 HSAs having investments, marking a 19.6% rise [12] - Total HSA assets grew by 22.2% year over year, including both HSA cash and investments [12] Competitive Landscape - HealthEquity faces stiff competition in the Medical Services market, which is rapidly evolving and fragmented [4] - The company's success is heavily reliant on consumer adoption of Health Savings Accounts (HSAs) and its ability to demonstrate value to clients [4] Estimate Trends - There has been a positive estimate revision trend for fiscal 2025, with the Zacks Consensus Estimate for earnings per share increasing by 3.4% to $3.00 [16] - The revenue estimate for the second quarter of fiscal 2025 is projected at $284.5 million, indicating a 16.8% increase from the previous year [16]

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. Zacks Premium includes access to the Zacks Style Scores as well. What are the Zacks Style Scores? T ...

With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) company appears to be a solid wealth creator for its investors at the moment. Catalysts Driving Growth HealthEquity, Inc. (HQY) witnessed strong momentum in the year-to-date period. Shares of the company rallied 25.3% compared with 4.7% growth of the industry. The S&P 500 Composite has risen 7% during the same time frame. Draper, UT-headquartered HealthEquity provides integrated solutions for healthcare account management, h ...

HealthEquity Today Add to Watchlist The company operates in the medical sector and competes with other providers of HSAs, including UnitedHealth Group Inc. NYSE: UNH, Webster Financial Co. NYSE: WBS and Fidelity National Financial Inc. NYSE: FNF. What is a Health Savings Account? What is a Flexible Spending Account? HQY Triggers a Daily Bull Flag Breakout Pattern HealthEquity reported a Q1 2025 beat by 15 cents. Net income rose to $28.8 million, up from $4.1 million in the year-ago period. Adjusted EBITDA w ...

Core Insights - HealthEquity, Inc. reported strong financial results for the first quarter of fiscal 2025, with adjusted earnings per share (EPS) of 80 cents, exceeding the Zacks Consensus Estimate by 21.2% and showing a year-over-year improvement of 60% [1] - The company generated revenues of $287.6 million, surpassing the Zacks Consensus Estimate by 3.2% and reflecting a 17.7% increase from the prior-year quarter [2] Revenue and Accounts - As of April 30, 2024, HealthEquity served 9.1 million Health Savings Accounts (HSA) members, a 13.1% increase year over year, with 665,000 HSAs having investments, up 19.6% year over year [3] - Total HSA assets reached $27.28 billion, up 22.2% year over year, including $15.85 billion in HSA cash (up 12.3%) and $11.43 billion in HSA investments (up 39.3%) [4] Revenue Sources - HealthEquity's revenue streams include service revenues of $118.2 million (up 6.4% year over year), custodial revenues of $121.6 million (up 37.5%), and interchange revenues of $47.7 million (up 6.4%) [6][8] Profitability and Margins - Gross profit increased by 26% to $187.1 million, with a gross margin expansion of 433 basis points to 65.1% [9] - Adjusted operating profit rose 39.2% to $69.3 million, with an adjusted operating margin expanding 373 basis points to 24.1% [11] Financial Position - At the end of the first quarter of fiscal 2025, the company had cash and cash equivalents of $251.2 million, down from $403.9 million at the end of fiscal 2024, and total debt increased to $925.7 million [12] Guidance - HealthEquity raised its revenue and EPS projections for fiscal 2025, now expecting revenues between $1.16 billion and $1.18 billion and adjusted EPS in the range of $2.93 to $3.10 [13] Overall Performance - The company experienced solid top-line and bottom-line performances, driven by robust contributions from all revenue sources and growth in HSAs, while the decline in Consumer Direct Benefits (CDBs) and client-held funds was noted as a disappointment [14][15]

Here is how HealthEquity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: View all Key Company Metrics for HealthEquity here>>> Shares of HealthEquity have returned +4% over the past month versus the Zacks S&P 500 composite's +5.1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. For the quarter ended April 2024, HealthEquity (HQY) reported revenue of $287 ...

HealthEquity (HQY) came out with quarterly earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.50 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 21.21%. A quarter ago, it was expected that this provider of services for managing health care accounts would post earnings of $0.56 per share when it actually produced earnings of $0.63, delivering a surprise of 12.5 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-36568 HEALTHEQUITY, INC. (Exact name of registrant as specified in its charter) Delaware 52-2383166 (State or other jurisdiction of incorporation or organization) (I.R.S. E ...

HealthEquity Reports First Quarter Ended April 30, 2024 Financial Results Highlights of the first quarter include: Draper, Utah – June 3, 2024 – HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced financial results for its first quarter ended April 30, 2024. "Record first quarter HSA sales, greater Enhanced Rates adoption, and timely transition of two of three BenefitWallet tranches made for a great team start to ...